person

Silverio P.

Country
Italy
Department
U.O.C. Oncologia Medica ed Ematologia, Dipartimento di Medicina di Precisione

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
32
Sites with multiple studies

Has run more than one trial at 32 of 94 partner sites.

Specializations

Hematological Disorders

The investigator specializes in treating various forms of thalassemia, including both alpha and beta variants, with particular focus on transfusion-dependent cases. Their research encompasses innovative therapeutic approaches for managing hemoglobinopathies and related blood disorders.

  • Alpha-thalassemia management
  • Beta-thalassemia treatment
  • Transfusion dependency optimization

Sickle Cell Disease

Extensive work in sickle cell disease treatment, focusing on developing therapeutic solutions for managing vaso-occlusive episodes and related complications. The investigator studies novel approaches to address anemia in SCD patients.

  • Pain crisis management
  • Anemia treatment
  • Disease modification therapies

Oncology and Rare Diseases

The investigator conducts research in neuroblastoma treatment strategies and management of neurofibromatosis type 1. Their work includes evaluation of novel therapeutic approaches for inoperable plexiform neurofibromas.

  • High-risk neuroblastoma treatment
  • Neurofibromatosis management
  • Rare disease therapeutics

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.